| Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study S Pilakka-Kanthikeel, VSR Atluri, V Sagar, SK Saxena, M Nair PloS one 8 (4), e62241, 2013 | 161 | 2013 |
| Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study S Pilakka-Kanthikeel, VSR Atluri, V Sagar, SK Saxena, M Nair PloS one 8 (4), e62241, 2013 | 161 | 2013 |
| Enhanced blood–brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation H Ding, V Sagar, M Agudelo, S Pilakka-Kanthikeel, VSR Atluri, ... Nanotechnology 25 (5), 055101, 2014 | 135 | 2014 |
| Microglia-derived HIV Nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of Nef peptides AD Raymond, P Diaz, S Chevelon, M Agudelo, A Yndart-Arias, H Ding, ... Journal of neurovirology 22, 129-139, 2016 | 102 | 2016 |
| Towards nanomedicines for neuroAIDS V Sagar, S Pilakka‐Kanthikeel, R Pottathil, SK Saxena, M Nair Reviews in medical virology 24 (2), 103-124, 2014 | 92 | 2014 |
| Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination … S Pallikkuth, S Pilakka Kanthikeel, SY Silva, M Fischl, R Pahwa, S Pahwa The Journal of Immunology 186 (11), 6173-6181, 2011 | 89 | 2011 |
| Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays A Weinberg, LY Song, CL Wilkening, T Fenton, J Hural, R Louzao, ... Journal of immunological methods 363 (1), 42-50, 2010 | 71 | 2010 |
| Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND) VSR Atluri, SP Kanthikeel, PVB Reddy, A Yndart, MPN Nair PloS one 8 (4), e61399, 2013 | 63 | 2013 |
| Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome … PM Grant, L Komarow, MM Lederman, S Pahwa, AR Zolopa, J Andersen, ... The Journal of infectious diseases 206 (11), 1715-1723, 2012 | 63 | 2012 |
| Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy S Pilakka-Kanthikeel, S Huang, T Fenton, W Borkowsky, CK Cunningham, ... The Pediatric infectious disease journal 31 (6), 583-591, 2012 | 51 | 2012 |
| Cocaine enhances HIV-1 infectivity in monocyte derived dendritic cells by suppressing microRNA-155 J Napuri, S Pilakka-Kanthikeel, A Raymond, M Agudelo, A Yndart-Arias, ... PloS one 8 (12), e83682, 2013 | 47 | 2013 |
| Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive … VSR Atluri, S Pilakka-Kanthikeel, T Samikkannu, V Sagar, KRV Kurapati, ... Molecular brain 7, 1-17, 2014 | 45 | 2014 |
| Interactive effects of morphine on HIV infection: role in HIV-associated neurocognitive disorder PVB Reddy, S Pilakka-Kanthikeel, SK Saxena, Z Saiyed, MPN Nair AIDS research and treatment 2012, 2012 | 44 | 2012 |
| Sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1)-facilitated HIV restriction in astrocytes is regulated by miRNA-181a S Pilakka-Kanthikeel, A Raymond, VSR Atluri, V Sagar, SK Saxena, ... Journal of neuroinflammation 12, 1-12, 2015 | 43 | 2015 |
| Effect of cocaine on HIV infection and inflammasome gene expression profile in HIV infected macrophages VSR Atluri, S Pilakka-Kanthikeel, G Garcia, RD Jayant, V Sagar, ... Scientific reports 6 (1), 27864, 2016 | 40 | 2016 |
| Therapeutical neurotargeting via magnetic nanocarrier: implications to opiate-induced neuropathogenesis and neuroAIDS V Sagar, S Pilakka-Kanthikeel, VSR Atluri, H Ding, AY Arias, RD Jayant, ... Journal of biomedical nanotechnology 11 (10), 1722-1733, 2015 | 39 | 2015 |
| Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue U Roy, H Ding, S Pilakka-Kanthikeel, AD Raymond, V Atluri, A Yndart, ... International journal of nanomedicine, 5819-5835, 2015 | 36 | 2015 |
| Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting S Pilakka-Kanthikeel, A Kris, A Selvaraj, S Swaminathan, S Pahwa JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (1), 16-24, 2014 | 35 | 2014 |
| Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients S Pallikkuth, SP Kanthikeel, SY Silva, M Fischl, R Pahwa, S Pahwa Journal of allergy and clinical immunology 128 (6), 1279-1285, 2011 | 32 | 2011 |
| Interaction of drugs of abuse and microRNA with HIV: a brief review S Pilakka-Kanthikeel, MPN Nair Frontiers in microbiology 6, 155002, 2015 | 25 | 2015 |
Venkata AtluriAssociate Professor at Noorda College of Osteopathic MedicineVerified email at noordacom.org
